ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant DNA Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-16X8121
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Recombinant DNA Vaccine Market Insights Forecast to 2027
BUY CHAPTERS

Global Recombinant DNA Vaccine Market Research Report 2025

Code: QYRE-Auto-16X8121
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Recombinant DNA Vaccine Market Size

The global market for Recombinant DNA Vaccine was valued at US$ 243 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 15.3% during the forecast period.

Recombinant DNA Vaccine Market

Recombinant DNA Vaccine Market

Recombinant DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant DNA Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant DNA Vaccine.
The Recombinant DNA Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant DNA Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant DNA Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant DNA Vaccine Market Report

Report Metric Details
Report Name Recombinant DNA Vaccine Market
Accounted market size in year US$ 243 million
Forecasted market size in 2031 US$ 651 million
CAGR 15.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Human
  • Animal
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant DNA Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant DNA Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant DNA Vaccine Market growing?

Ans: The Recombinant DNA Vaccine Market witnessing a CAGR of 15.3% during the forecast period 2025-2031.

What is the Recombinant DNA Vaccine Market size in 2031?

Ans: The Recombinant DNA Vaccine Market size in 2031 will be US$ 651 million.

Who are the main players in the Recombinant DNA Vaccine Market report?

Ans: The main players in the Recombinant DNA Vaccine Market are Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals, Plumbline Life Sciences

What are the Application segmentation covered in the Recombinant DNA Vaccine Market report?

Ans: The Applications covered in the Recombinant DNA Vaccine Market report are Human, Animal

What are the Type segmentation covered in the Recombinant DNA Vaccine Market report?

Ans: The Types covered in the Recombinant DNA Vaccine Market report are Recombinant Protein Vaccine, Gene-Based Vaccine

Recommended Reports

DNA & Gene Therapies

Vaccine Delivery & Devices

Influenza & Flu Vaccines

1 Recombinant DNA Vaccine Market Overview
1.1 Product Definition
1.2 Recombinant DNA Vaccine by Type
1.2.1 Global Recombinant DNA Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Recombinant DNA Vaccine by Application
1.3.1 Global Recombinant DNA Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Human
1.3.3 Animal
1.4 Global Recombinant DNA Vaccine Market Size Estimates and Forecasts
1.4.1 Global Recombinant DNA Vaccine Revenue 2020-2031
1.4.2 Global Recombinant DNA Vaccine Sales 2020-2031
1.4.3 Global Recombinant DNA Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant DNA Vaccine Market Competition by Manufacturers
2.1 Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant DNA Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant DNA Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant DNA Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant DNA Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant DNA Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Recombinant DNA Vaccine, Date of Enter into This Industry
2.8 Global Recombinant DNA Vaccine Market Competitive Situation and Trends
2.8.1 Global Recombinant DNA Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant DNA Vaccine Players Market Share by Revenue
2.8.3 Global Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant DNA Vaccine Market Scenario by Region
3.1 Global Recombinant DNA Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant DNA Vaccine Sales by Region: 2020-2031
3.2.1 Global Recombinant DNA Vaccine Sales by Region: 2020-2025
3.2.2 Global Recombinant DNA Vaccine Sales by Region: 2026-2031
3.3 Global Recombinant DNA Vaccine Revenue by Region: 2020-2031
3.3.1 Global Recombinant DNA Vaccine Revenue by Region: 2020-2025
3.3.2 Global Recombinant DNA Vaccine Revenue by Region: 2026-2031
3.4 North America Recombinant DNA Vaccine Market Facts & Figures by Country
3.4.1 North America Recombinant DNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant DNA Vaccine Sales by Country (2020-2031)
3.4.3 North America Recombinant DNA Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant DNA Vaccine Market Facts & Figures by Country
3.5.1 Europe Recombinant DNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant DNA Vaccine Sales by Country (2020-2031)
3.5.3 Europe Recombinant DNA Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant DNA Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant DNA Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant DNA Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant DNA Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant DNA Vaccine Market Facts & Figures by Country
3.7.1 Latin America Recombinant DNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant DNA Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Recombinant DNA Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant DNA Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant DNA Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant DNA Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant DNA Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant DNA Vaccine Sales by Type (2020-2031)
4.1.1 Global Recombinant DNA Vaccine Sales by Type (2020-2025)
4.1.2 Global Recombinant DNA Vaccine Sales by Type (2026-2031)
4.1.3 Global Recombinant DNA Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Recombinant DNA Vaccine Revenue by Type (2020-2031)
4.2.1 Global Recombinant DNA Vaccine Revenue by Type (2020-2025)
4.2.2 Global Recombinant DNA Vaccine Revenue by Type (2026-2031)
4.2.3 Global Recombinant DNA Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant DNA Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant DNA Vaccine Sales by Application (2020-2031)
5.1.1 Global Recombinant DNA Vaccine Sales by Application (2020-2025)
5.1.2 Global Recombinant DNA Vaccine Sales by Application (2026-2031)
5.1.3 Global Recombinant DNA Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Recombinant DNA Vaccine Revenue by Application (2020-2031)
5.2.1 Global Recombinant DNA Vaccine Revenue by Application (2020-2025)
5.2.2 Global Recombinant DNA Vaccine Revenue by Application (2026-2031)
5.2.3 Global Recombinant DNA Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant DNA Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Recombinant DNA Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Recombinant DNA Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Recombinant DNA Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Company Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zoties Recombinant DNA Vaccine Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Company Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Recombinant DNA Vaccine Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Company Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer-Ingelheim Recombinant DNA Vaccine Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.7.1 Indian Immunologicals Company Information
6.7.2 Indian Immunologicals Description and Business Overview
6.7.3 Indian Immunologicals Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Indian Immunologicals Recombinant DNA Vaccine Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Company Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Recombinant DNA Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Plumbline Life Sciences Recombinant DNA Vaccine Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant DNA Vaccine Industry Chain Analysis
7.2 Recombinant DNA Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant DNA Vaccine Production Mode & Process Analysis
7.4 Recombinant DNA Vaccine Sales and Marketing
7.4.1 Recombinant DNA Vaccine Sales Channels
7.4.2 Recombinant DNA Vaccine Distributors
7.5 Recombinant DNA Vaccine Customer Analysis
8 Recombinant DNA Vaccine Market Dynamics
8.1 Recombinant DNA Vaccine Industry Trends
8.2 Recombinant DNA Vaccine Market Drivers
8.3 Recombinant DNA Vaccine Market Challenges
8.4 Recombinant DNA Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Plumbline Life Sciences
List of Tables
 Table 1. Global Recombinant DNA Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant DNA Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant DNA Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant DNA Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant DNA Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant DNA Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant DNA Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant DNA Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant DNA Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant DNA Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant DNA Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant DNA Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant DNA Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant DNA Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant DNA Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant DNA Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant DNA Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant DNA Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant DNA Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant DNA Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant DNA Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant DNA Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant DNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant DNA Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant DNA Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant DNA Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant DNA Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant DNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant DNA Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant DNA Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant DNA Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant DNA Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant DNA Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant DNA Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant DNA Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant DNA Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant DNA Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant DNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant DNA Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant DNA Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant DNA Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant DNA Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant DNA Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant DNA Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant DNA Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant DNA Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant DNA Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant DNA Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant DNA Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant DNA Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant DNA Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant DNA Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant DNA Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant DNA Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant DNA Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant DNA Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant DNA Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant DNA Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant DNA Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant DNA Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant DNA Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant DNA Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant DNA Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant DNA Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant DNA Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant DNA Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant DNA Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Recombinant DNA Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Recombinant DNA Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Recombinant DNA Vaccine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Zoties Company Information
 Table 86. Zoties Description and Business Overview
 Table 87. Zoties Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Zoties Recombinant DNA Vaccine Product
 Table 89. Zoties Recent Developments/Updates
 Table 90. Elanco Company Information
 Table 91. Elanco Description and Business Overview
 Table 92. Elanco Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Elanco Recombinant DNA Vaccine Product
 Table 94. Elanco Recent Developments/Updates
 Table 95. Boehringer-Ingelheim Company Information
 Table 96. Boehringer-Ingelheim Description and Business Overview
 Table 97. Boehringer-Ingelheim Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Boehringer-Ingelheim Recombinant DNA Vaccine Product
 Table 99. Boehringer-Ingelheim Recent Developments/Updates
 Table 100. Indian Immunologicals Company Information
 Table 101. Indian Immunologicals Description and Business Overview
 Table 102. Indian Immunologicals Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Indian Immunologicals Recombinant DNA Vaccine Product
 Table 104. Indian Immunologicals Recent Developments/Updates
 Table 105. Plumbline Life Sciences Company Information
 Table 106. Plumbline Life Sciences Description and Business Overview
 Table 107. Plumbline Life Sciences Recombinant DNA Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Plumbline Life Sciences Recombinant DNA Vaccine Product
 Table 109. Plumbline Life Sciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Recombinant DNA Vaccine Distributors List
 Table 113. Recombinant DNA Vaccine Customers List
 Table 114. Recombinant DNA Vaccine Market Trends
 Table 115. Recombinant DNA Vaccine Market Drivers
 Table 116. Recombinant DNA Vaccine Market Challenges
 Table 117. Recombinant DNA Vaccine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant DNA Vaccine
 Figure 2. Global Recombinant DNA Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant DNA Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Protein Vaccine Product Picture
 Figure 5. Gene-Based Vaccine Product Picture
 Figure 6. Global Recombinant DNA Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant DNA Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Human
 Figure 9. Animal
 Figure 10. Global Recombinant DNA Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Recombinant DNA Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Recombinant DNA Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Recombinant DNA Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Recombinant DNA Vaccine Report Years Considered
 Figure 15. Recombinant DNA Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Recombinant DNA Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Recombinant DNA Vaccine Players: Market Share by Revenue in Recombinant DNA Vaccine in 2024
 Figure 18. Recombinant DNA Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Recombinant DNA Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Recombinant DNA Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Recombinant DNA Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Recombinant DNA Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Recombinant DNA Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Recombinant DNA Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Recombinant DNA Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Recombinant DNA Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Recombinant DNA Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Recombinant DNA Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Recombinant DNA Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Recombinant DNA Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Recombinant DNA Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Recombinant DNA Vaccine by Type (2020-2031)
 Figure 54. Global Recombinant DNA Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Recombinant DNA Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Recombinant DNA Vaccine by Application (2020-2031)
 Figure 57. Global Recombinant DNA Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Recombinant DNA Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global DNA Vaccines Market Insights Forecast to 2030
Global DNA Vaccination Market Research Report 2024
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Global Recombinant Vector Vaccines Market Insights Forecast to 2030
Global Genetic Vaccine Market Insights Forecast to 2030
Global Nucleic Vaccine Market Insights Forecast to 2030
Global Pet DNA Vaccines Market Research Report 2025
Global Recombinant Influenza Vaccine Market Research Report 2024
Recombinant Protein Therapeutics Market
Global Human DNA Vaccines Market Insights Forecast to 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Recombinant Protein Market Research Report 2024
Global Pet Recombinant Vaccine Market Research Report 2025
Global Nucleic Acid Vaccine Market Insights Forecast to 2030
Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Recombinant Protein Expression System Market Research Report 2024
Recombinant DNA Technology Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions